Drug Master Files for: doxazosin mesylate
✉ Email this page to a colleague
doxazosin mesylate Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
12634 | A | II | 8/27/1997 | EXCELLA GMBH AND CO KG | DOXAZOSIN MESYLATE |
12750 | A | II | 11/14/1997 | DR REDDYS LABORATORIES LTD | DOXAZOSIN MESYLATE USP |
12784 | I | II | 12/12/1997 | CIPLA LTD | DOXAZOSIN MESYLATE |
13039 | A | II | 6/22/1998 | APOTEX PHARMACHEM INDIA PVT LTD | DOXAZOSIN MESYLATE USP |
13807 | I | II | 10/29/1998 | BASF PHARMACHEMIKALIEN GMBH CO KG | DOXAZOSIN MESYLATE |
14173 | I | II | 6/3/1999 | CILAG AG | DOXAZOSIN MESYLATE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information